Literature DB >> 21809139

Evaluation of the phenotype pattern of macrophages isolated from malignant and non-malignant pleural effusions.

Mariusz Kaczmarek1, Agata Nowicka, Magdalena Kozłowska, Jakub Zurawski, Halina Batura-Gabryel, Jan Sikora.   

Abstract

Macrophages are among the infiltrate components of most malignant tumors. Tumor-associated macrophages (TAMs) may secrete a variety of humoral factors, which promote or inhibit tumor growth. In general, depending on their activation pathway, macrophages exhibit two different patterns of phenotype, M1 or M2. It is assumed that TAMs comprise pattern M2. In the malignant pleural effusion, macrophages are a frequent component of cytological evaluation. In this microenvironment, TAMs could be involved in the development of immunity. The phenotype of macrophages represented in malignant and non-malignant pleural effusions is unknown. In this study, macrophages were isolated from 38 pleural effusions (15 malignant and 23 non-malignant) and the expression of a variety of immune mediators and their receptors was assessed to determine the type of activation (M1 vs. M2). The expression of mRNA was analyzed for IL-1β, IL-4, IL-6, IL-10, IL-11, IL-18, TNFα, TGFβ1, IL1R1, IL1RAP, TLR2, TLR4, VLA4, CD62L, MMP2, MMP9, VEGFA, PDGFA, and PDGFB. In immunohistochemical evaluation, the expressions of CD68, mesothelin, MAC387, IL-1β, IL-6, IL-10, IL-12, TNFα, and CD105 were assessed. The cytoplasmic expression of IFNγ, TNFα, IL-6, and IL-10 and the surface expression of CD11a, CD14, CD15, CD16, CD23, CD25, CD45, CD54, CD62L, CD69, VLA2, VLA3, VLA4, VLA6, TLR2, TLR4, and CCR7 were tested using flow cytometry. In supernatants from macrophages cultures, TNFα, IL-1β, IL-6, IL-8, IL-10, IL-12, MCP1, and VEGF were investigated by cytometric beads array method (CBA flex sets) and TGFβ1 by ELISA. Our results indicate that macrophages from malignant and non-malignant pleural effusions differ from each other and suggest that macrophages isolated from non-malignant effusions show a pattern comparable to M1 while those isolated from malignant effusions express similarity to M2 phenotype, but they have not shown a classical M2 pattern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809139     DOI: 10.1007/s13277-011-0214-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

Review 1.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

Review 2.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

Review 3.  Monocyte and macrophage heterogeneity.

Authors:  Siamon Gordon; Philip R Taylor
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

4.  Immunologic characterization of normal human pleural macrophages.

Authors:  M Frankenberger; B Passlick; T Hofer; M Siebeck; K L Maier; L H Ziegler-Heitbrock
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

5.  Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta.

Authors:  J S Park; Y S Kim; Y K Jee; N H Myong; K Y Lee
Journal:  Scand J Immunol       Date:  2003-05       Impact factor: 3.487

6.  The local cytokine and chemokine milieu within malignant effusions.

Authors:  Djordje Atanackovic; Yanran Cao; Ji-Won Kim; Stephan Brandl; Ina Thom; Christiane Faltz; York Hildebrandt; Katrin Bartels; Andreas de Weerth; Susanna Hegewisch-Becker; Dieter Kurt Hossfeld; Carsten Bokemeyer
Journal:  Tumour Biol       Date:  2008-06-02

Review 7.  CCR7 and its ligands: balancing immunity and tolerance.

Authors:  Reinhold Förster; Ana Clara Davalos-Misslitz; Antal Rot
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

8.  MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitidis.

Authors:  Subhankar Mukhopadhyay; Yunying Chen; Marko Sankala; Leanne Peiser; Timo Pikkarainen; Georg Kraal; Karl Tryggvason; Siamon Gordon
Journal:  Eur J Immunol       Date:  2006-04       Impact factor: 5.532

Review 9.  Diagnosis and management of malignant pleural effusions.

Authors:  K N Fenton; J D Richardson
Journal:  Am J Surg       Date:  1995-07       Impact factor: 2.565

Review 10.  The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.

Authors:  L Bingle; N J Brown; Claire E Lewis
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

View more
  11 in total

1.  PSMB5 plays a dual role in cancer development and immunosuppression.

Authors:  Chih-Yang Wang; Chung-Yen Li; Hui-Ping Hsu; Chien-Yu Cho; Meng-Chi Yen; Tzu-Yang Weng; Wei-Ching Chen; Yu-Hsuan Hung; Kuo-Ting Lee; Jui-Hsiang Hung; Yi-Ling Chen; Ming-Derg Lai
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

2.  Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.

Authors:  Jane R Engler; Aaron E Robinson; Ivan Smirnov; J Graeme Hodgson; Mitchel S Berger; Nalin Gupta; C David James; Annette Molinaro; Joanna J Phillips
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

3.  Differences in the distribution, phenotype and gene expression of subretinal microglia/macrophages in C57BL/6N (Crb1 rd8/rd8) versus C57BL6/J (Crb1 wt/wt) mice.

Authors:  Bogale Aredo; Kaiyan Zhang; Xiao Chen; Cynthia Xin-Zhao Wang; Tao Li; Rafael L Ufret-Vincenty
Journal:  J Neuroinflammation       Date:  2015-01-15       Impact factor: 8.322

4.  Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions.

Authors:  Joanna Budna; Mariusz Kaczmarek; Agata Kolecka-Bednarczyk; Łukasz Spychalski; Piotr Zawierucha; Joanna Goździk-Spychalska; Michał Nowicki; Halina Batura-Gabryel; Jan Sikora
Journal:  J Immunol Res       Date:  2018-03-26       Impact factor: 4.818

5.  Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.

Authors:  Nayoung Kim; Hong Kwan Kim; Kyungjong Lee; Yourae Hong; Jong Ho Cho; Jung Won Choi; Jung-Il Lee; Yeon-Lim Suh; Bo Mi Ku; Hye Hyeon Eum; Soyean Choi; Yoon-La Choi; Je-Gun Joung; Woong-Yang Park; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn; Hae-Ock Lee
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

6.  MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma.

Authors:  Lei Li; Pengfei Sun; Chengsheng Zhang; Zongchao Li; Kai Cui; Wuyuan Zhou
Journal:  Cancer Cell Int       Date:  2018-07-06       Impact factor: 5.722

7.  Macrophages in malignant pleural effusions - alternatively activated tumor associated macrophages.

Authors:  Mariusz Kaczmarek; Jan Sikora
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

8.  TLR2 in pleural fluid is modulated by talc particles during pleurodesis.

Authors:  Karolina Jankovicova; Katerina Kondelkova; Petr Habal; Ctirad Andrys; Jan Krejsek; Jiri Mandak
Journal:  Clin Dev Immunol       Date:  2012-12-10

9.  Different subsets of macrophages in patients with new onset tuberculous pleural effusion.

Authors:  Ying Tang; Shu-Cheng Hua; Gui-Xiang Qin; Li-Jun Xu; Yan-Fang Jiang
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

10.  Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Authors:  Da Hyun Kang; Chaeuk Chung; Ju-Ock Kim; Sung Soo Jung; Hee Sun Park; Dong Il Park; Sun Young Jung; Myoungrin Park; Jeong Eun Lee
Journal:  Thorac Cancer       Date:  2018-09-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.